(RTTNews) - West Pharmaceutical Services, Inc. (WST) said, for full-year 2025, the company expects: adjusted EPS to be in a range of $6.00 to $6.20; and net sales to be in a range of $2.875 billion to $2.905 billion. Organic net sales growth is expected to be approximately 2% to 3%. Analysts on average expect the company to report profit per share of $7.43. Analysts' estimates typically exclude special items.
Fourth-quarter reported EPS was $1.78, declined 2.7% from a year ago. Adjusted EPS was $1.82, declined 0.5%. Analysts on average had expected the company to earn $1.73 per share. Net sales were $748.8 million, increased 2.3%. Organic net sales grew 3.3%.
Shares of West Pharmaceutical Services are down 11% in pre-market trade on Thursday.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
